
News from biopharmadive.com
Media Bias Ratings
Average Bias Rating:
Center
Center
byMedia Bias/Fact CheckDo you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top biopharmadive.com News
France's Sanofi to acquire biotech firm Vicebio for $1.15 billion
84% Center coverage: 13 sources
FDA Rejects Replimune's Blood Cancer Drug, Stock Sinks - Replimune Group (NASDAQ:REPL)
60% Center coverage: 5 sources
FDA to consider warning against antidepressants
46% Left coverage: 26 sources
Why Is Alkermes Stock Falling On Monday? - Alkermes (NASDAQ:ALKS)
100% Center coverage: 3 sources